During early development of mammalian cerebral cortex, newly generated neurons migrate, accumulate in layers, and extend growth cone-guided processes to establish local and distant interconnections. The molecular interactions responsible for these events in cortex are at present largely undefined, but in other parts of the embryo extracellular matrix (ECM) components play an important role in many major developmental rearrangements including gastrulation (Boucaut et al., 1984 ) the migration of primordial germ cells (Donovan et al., 1987) and the migration and accumulation of neural crest cells (Bronner-Fraser, 1986; Duband et al., 1986; Rogers et al., 1986; Stemberg and Kimber, 1986) . Although a matter of controversy for many years, it now seems clear that ECM components are involved in development of the CNS as well (Sanes, 1989; Reichardt and Tomaselli, 199 1) . Glycosaminoglycans, defined by labeling with cationic dyes, are present in the cerebral cortex of the mouse (Derer and Nakanishi, 1983; Nakanishi, 1983; Bruckner et al., 1985) and in the chick's optic tectum just ahead of arriving optic nerve axons (Krayanek, 1980) . Immunolabeling with antibodies against fibronectin (IN; Hatten et al., 1982; Stewart and Pearlman, 1987; Chun and Shatz, 1988; Stallcup et al., 1989 ) proteoglycans (Aquino et al., 1984 Margolis and Margolis, 1989; Snow et al., 1990b), hyaluronectin (Delpech and Delpech, 1984; Bignami and Delpech, 1985) , laminin (Liesi, 1985; Letoumeau et al., 1988; Liesi and Silver, 1988; McLoon et al., 1988; Hagg et al., 1989) , tenascin (Crossin et al., 1989; Steindler et al., 1989) , and thrombospondin (O'Shea et al., 1990) has been demonstrated in the developing CNS of the rodent, and extracellular material that has not been characterized with antibody markers is evident with electron microscopy in the cortical subplate and marginal zones (Derer and Nakanishi, 1983; Nakanishi, 1983; Hankin and Silver, 1988 ).
An understanding of the role of individual ECM components in cortical development will require a precise definition of the timing and location of their expression. To this end, we have used immunolabeling to determine the spatial and temporal distribution of three major classes of ECM components, IN, chondroitin sulfate proteoglycan (CSPG), and tenascin, in the developing cerebral cortex of the mouse from embryonic day 11 (El 1) through postnatal day 14 (P14). The FNs are a set of large, dimeric glycoproteins, produced from a single gene by alternative splicing, that are involved in cell adhesion, migration, and differentiation (Hynes, 1990) . Chondroitin sulfate is one of several types of glycosaminoglycan that are covalently linked to various protein cores to form the large family of proteoglycans present in ECM and on cell surface membranes (Gallagher, 1989) . There is evidence that CSPGs may restrict migration of neural crest cells (Tucker and Erickson, 1984; Perris and Johansson, 1990) and may also inhibit neutite outgrowth in culture (Snow et al., 1990a) . Tenascin, which is similar or identical to GMEM (Bourdon et al., 1983) , myotendinous antigen (Chiquet and Fambrough, 1984) , hexabrachion protein (Erickson and Iglesias, 1984) , cytotactin (Grumet et al., 1985) , and J 1 2oo1220 (&use et al., 1985) , is a modular glycoprotein that is prominently expressed during development and tumor formation (Chiquet, 1989; Erickson and Bourdon, 1989) . Conflicting roles have been ascribed to tenascin; it has been suggested that it provides a barrier to neural crest cell migration (Tan et al., 1987; Bronner-Fraser, 1988) and neurite outgrowth (Steindler et al., 1989; Faissner and Kruse, 1990) , but may support migration of cerebellar granule cells (Chuong et al., 1987 A preliminary report of this work has appeared in abstract form (Sheppard and Pearlman, 1990) .
Materials and Methods
Antibodies. The following primary antibodies were used to label sections: an affinity-purified polyclonal antiserum (rabbit) to human fibronectin (abFN; 1:200; provided by J. McDonald and T. Broekelman; Villiger et al., 1981) ; an antiserum (rabbit) to human tenascin (abTEN, IgG fraction, 1:25; provided by M. Bourdon); a monoclonal antibody to chondroitin sulfate proteoglycan (abCSPG; Sigma; 1:600; Avnur and Geiger, 1984); monoclonal antibodies RCl and RC2 (undiluted hybridoma supematants derived from cells provided by M. Yamamoto), which label cytoskeletal proteins of radial glia (Misson et al., 1988; Culican et al., 1990; Edwards et al., 1990) (Stewart and Pearlman, 1987) . Briefly, timed pregnancies were produced by matings of C57B1/6J mice (Jackson Labs, Bar Harbor, ME). Females were checked for vaginal plugs each morning; the day of conception was designated embryonic day 0 (EO). Embryos obtained by cesarian section were fixed by immersion in 4% paraformaldehyde in PBS (pH 7.4) for l-2 hr at 4°C. During fixation the scalp and skull were opened (El l-12) or the brain was removed from the skull (El3 and older). After rinses with PBS, brains were immersed in 30% sucrose overnight at 4°C frozen in liquid nitrogen, and sectioned (16-20 pm) with a cryostat. Sections were dried on gelatin-coated slides at room temperature and stored at -20°C until use. For immunolabeling with RCl, unfixed embryos were frozen in liquid nitrogen; cryostat sections were fixed briefly on the slide with paraformaldehyde (lo/& 2 min), rinsed in PBS, permeabilized with methyl alcohol (-70°C 5 min), then rinsed with PBS.
Immunolabeling was carried out in a dark, humidified chamber. All rinses were with PBS (pH 7.4) and antibody dilutions were in 1% fish gelatin (Sigma Chemical) in PBS. Tris-buffered saline was substituted for PBS for immunolabeling with the anti-neurofilament antibodies. Sections were rehydrated with buffer (5 min), blocked with 1% fish gelatin in buffer, and incubated with primary antibodies for 1 hr (RCl, RC2, and abNF) at room temperature, or overnight at 4°C (abFN, abCSPG. abTEN). For double labeling with RCI or RC2 and abFN. primary antibodies were applied seque>tially (abFN first) to avoid the prospect of labeling the small amount of fibronectin in the serum-containing hybridoma supematant. After three rinses, sections were incubated with fluorescently tagged secondary antibodies for 1 hr, rinsed, coverslipped after application of 0.0 1 O/a p-phenylenediamine (Sigma) in glycerin 198 l) , and examined with epifluorescence microscopy (Nikon Labophot).
Controls. In each experiment, control sections were incubated with nonimmune IgG or diluent instead of the primary antibody. As an additional control, sections from each age were incubated with abFN that had been preincubated with fibronectin (Stewart and Pearlman, 1987) . No labeling of the neuropil, blood vessels, or pia-arachnoid was apparent in these controls.
Antibody specificity. The following evidence indicates that the antiserum to fibronectin used in this study is likely to be labeling a molecule that is closely related to fibronectin: (1) abFN labeling is demonstrable with two different affinity-purified antisera (Stewart and Pearlman, 1987) one against human plasma fibronectin (Villiger et al., 1981) and the other against cellular fibronectin from the hamster (Schwarzbauer et al., 1983) ; (2) immunolabeling is abolished by preincubating the antiserum with fibronectin (Stewart and Pearlman, 1987) ; and (3) immunolabeling with a similar distribution is demonstrable with a different set of antibodies in both rat (Stallcup et al., 1989) and cat (Chun and Shatz, 1988) . The monoclonal antibody to CSPG has been shown to recognize chondroitin sulfate by solid-phase radioimmunoassay with purified glycosaminoglycans, sensitivity of the antigen to purified chondroitinases, and immunoprecipitation of sulfate-containing materials from cells and culture media (Avnur and Geiger, 1984) . The antibody may cross-react with heparan sulfate, but not with heparin or dermatin sulfate (Avnur and Geiger, 1984) . The antiserum to tenascin does not cross-react with laminin, fibronectin, or collagens I, III, and VI (M. Bourdon, personal communication).
The distribution of immunolabeling we demonstrate in cortex is similar to that found by other laboratories with two different antibodies (Godfraind et al., 1988; Crossin et al., 1989; Steindler et al., 1989) .
Semithin plastic sections. After immersion fixation for 2 hr (4% paraformaldehyde, 0.5% glutaraldehyde in phosphate buffer, pH 7.2), brains were rinsed in PBS; fixed for 30 min in 1% 0~0,; rinsed, dehydrated through a graded series of ethanol/H,0 solutions; immersed in propylene oxide (Polysciences) for 45 min, in 1: 1 propylene oxide/Araldite 502 (Polysciences) overnight, and then in undiluted Araldite for 7 hr; and cured at 60°C overnight. Sections 14 pm were cut on an ultramicrotome and stained with 1% toluidine blue (Fisher).
Results

Stages of early cortical development
To facilitate description of the experimental results, we have divided the events of early cortical development into three stages. In the ventricular zone (VZ) stage ( Fig. 1 ; El l), the dorsolateral wall of the telencephalic vesicle consists of a pseudostratified columnar epithelium made up of cells undergoing rapid division (Sauer, 1935; Angevine and Sidman, 1961) . zone (PPZ) stage ( Fig. 1 ; El 2) is characterized by the appearance of the first postmitotic neurons (Raedler and Raedler, 1978; Luskin and Shatz, 1985) , which form the two to three cell thick preplate zone (also called the primordial plexiform zone; MarinPadilla, 1978) just beneath the pia. In the cortical plate (CP) stage ( Fig. 1 ; E 13), cells that will eventually form the definitive layers of the cortex accumulate in a dense layer within the preplate. Formation ofthe cortical plate within the preplate (MarinPadilla, 1978) divides the latter into the marginal zone above and the subplate below; both the marginal zone and the subplate contain the former preplate cells (Retzius, 1893; Marin-Padilla, 197 1, 1972; Raedler and Raedler, 1978; Luskin and Shatz, 1985) . Each of these three stages of early cortical development has been arbitrarily assigned to an embryonic day based on its prominence on that day in the dorsolateral wall of the cerebral vesicle, approximately halfway between the anterior and posterior pole. Since there is a prominent ventrolateral to dorsomedial gradient in telencephalic development (Smart and Smart, 1982) , the PPZ stage actually appears gradually in the ventrolateral wall late on El 1 or early on E 12 and continues to be present in the dorsomedial wall late on E 12. The appearance of the cortical plate follows a similar progression, beginning late on El2 and extending through most of El 3.
Changing distribution of FN and CSPG In the VZ stage, immunoreactivity to abFN is evident as small punctate collections that are prominent around cells near the ventricular surface but extend throughout the cerebral wall (Fig.   2 , VZ stage). Immunolabeling with the abCSPG is similarly distributed. However, it is more prominent than abFN immunolabeling, and also more widespread rather than punctate (Fig. 2, VZ stage) . Intense immunoreactivity to both antibodies is present in the pia-arachnoid covering the brain; abFN labeling is also present in association with blood vessels (Fig. 2) .
As postmitotic neurons leave the ventricular zone to form the preplate, there is a striking shift in the distribution of immunoreactivity to abFN and abCSPG. Instead of the distribution throughout the cerebral wall evident in the VZ stage, the puncta of abFN labeling are primarily in the preplate zone, and abCSPG labeling becomes much more prominent in the same layer (Fig.  2 , PPZ stage). At this stage, immunolabeling with abNF first demonstrates neuronal processes in the lateral wall of the cerebral vesicle. The temporal relationship between the appearance of these processes and the change in distribution of abFN labeling is evident in a photographic montage of the dorsolateral wall of the telencephalic vesicle at E 12 (Fig. 3) . As a consequence of the ventrolateral to dorsomedial developmental gradient (Smart and Smart, 1982) , both the VZ stage and the PPZ stage are evident in a single coronal section. The initial shift in FN and CSPG distribution takes place just as the first processes become evident with abNF. These processes are confined to the FN-CSPG-rich preplate zone as they advance; most appear to arise directly from preplate cells and traverse the preplate tangentially for short distances.
The distribution of abFN and abCSPG labeling changes again as the cortical plate forms within the preplate. The cortical plate second antibody) and abCSPG (PITWagged second antibody). VZ stage, Punctate labeling (arrows) with abFN is present throughout the ventricular zone (VZ), which extends from the ventricle to the brightly labeled pia-arachnoid (PA), with somewhat more prominence near the ventricle. Labeling with abCSPG is similarly distributed, but less punctate. PPZ stage, Punctate labeling (arrows) with abFN is now primarily in the preplate zone (PPZ), and preplate labeling with abCSPG is very prominent. CP stage, Diffise labeling (between arrows) with abPN is present in the subplate (SP), and prominent labeling with abCSPG is evident in the subplate, marginal zone (MZ), and upper intermediate zone (ZZ) . Both FN and CSPG are almost completely absent from the cortical plate (CP). Scale bar, 20 pm.
is almost completely free of immunoreactivity; diffuse abFN labeling is present in this layer but is more difficult to demonand abCSPG labeling is prominent in the subplate beneath the strate there because of the very strong labeling of the immedicortical plate (Fig. 2, CP Stewart and Pearlman, 1987) . Labeling with abCSPG remains strong in both the marginal zone and subplate layers during the late CP stage (see Fig.  6 , CP stage-late), but declines soon thereafter as cortical differentiation begins (see Fig. 6 , CTX stage-early). Thus, both FN and CSPG are closely related to preplate cells during the PPZ and CP stages, when both are largely restricted to the layers containing these cells, that is, the preplate itself and the subplate and marginal zones that are formed from it.
Relationship of FN to radial glia during early developmental stages
In many sections of the early telencephalic wall, the puncta of abFN immunoreactivity appear to be radially aligned, suggesting an association with radial glia. To examine this prospect, we double labeled frozen sections with abFN and RCl or RC2, monoclonal antibodies that label radial glia of the mouse in sections (Misson et al., 1988; Edwards et al., 1990) and in tissue culture (Culican et al., 1990) . Photographic double exposures demonstrate the relationship between abFN labeling and radial glial labeling (Figs. 4,5 ). In the VZ stage, punctate abFN labeling is distributed in linear arrays along radial processes labeled with RCl or RC2 and is also prominent around the cells near the ventricular surface (Fig. 4A) . As the shift in abFN labeling takes place with the formation of the preplate zone (Figs. 4B, 5 ), the puncta in the preplate continue to correspond to processes labeled with RCl or RC2. Puncta of abFN labeling in the subplate after cortical plate formation are also aligned with radial glia (Figs. 4C, 5) . Thus, although the distribution of FN changes in conjunction with the preplate cells during early cortical development as described above, it also maintains a consistent relationship to radial glia.
Tenascin immunolabeling and cortical d@erentiation
As the cortical plate reaches maximal thickness, cells of the subplate are clearly demarcated from it and from the underlying intermediate zone by relatively cell-free layers (Fig. 6 , CP stagelate). For purposes of description, we have termed these cellfree zones sublaminae a and c of subplate, and the layer containing the subplate cells, sublamina b. Sublaminae a and c are rich in CSPG, as is the marginal zone. These layers are also the site ofthe first detectable labeling with abTEN (Fig. 6 , CP stagelate).
The gradual differentiation of cortical plate into cortex begins with the separation of neurons that lie deepest in the cortical plate into distinct laminae. Early lamination is evident in Nisslstained material by the increased distance between differentiating cell nuclei as compared to those in the cortical plate, and the formation of intervening layers that are relatively free of cell bodies (Fig. 6 , CTX stage-early). Immunolabeling with abTEN accompanies differentiation, gradually spreading upward as the progressive definition of cortical laminae occurs in c Figure 3 . Restriction of FN to preplate coincides with appearance of early cortical axons demonstrable with abNF labeling: photomicrographic montage and tracing of the cortex in the dorsolateral aspect of the cerebral hemisphere in coronal section at E12. The section was double labeled with abPN (TRITC-tagged second antibody) and abNF (PITC-tagged second antibody). The inset is an outline of the section for orientation. The dorsal surface (0) of the hemisphere is at the top, and the lateral aspect (L) is to the right. Since maturation proceeds from ventrolateral to dorsomedial, the VZ stage is present in the dorsal aspect of the section and the PPZ stage is present in the ventrolateral aspect. Arrows indicate ahNF-labeled afferent axons and exactly corresponding points in the abFN-labeled montage. The shift of abFN labeling to a restricted distribution within the preplate and the confinement of early axons to the FN-containing preplate are evident in the tracing, which superimposes the abPN and abNF montages. Intense abFN labeling is also present in association with the pia and blood vessels (shaded areas). Scale bar, 50 pm. inside-out fashion (Fig. 6 , CTX stage-early).
In contrast, labeling with abCSPG becomes undetectable at the beginning of cortical differentiation (Fig. 6 , CTX stage-early).
As cortical maturation continues in early postnatal life, the distribution of abTEN labeling spreads to involve all of the cortex and subcortical white matter except the small residual cortical plate where labeling is sparse (Fig. 7, P2) . By P4 the cortical plate is no longer evident, and abTEN labeling is present throughout the cortex (Fig. 7,  P4 ). The uniform distribution of abTEN immunolabeling with cortex is disrupted by the formation of the vibrissal barrels (Woolsey and Van der Loos, 1970) in the parietal somatosensory cortex. Immunolabeling is absent from the barrel hollows but remains in the barrel walls (Fig. 7, P7 ). Immunolabeling has declined substantially throughout the entire cortical wall by P 10, when it is seen primarily in association with blood vessels (Fig. 7, PlO) .
Discussion
During development of the cerebral cortex of the mouse, the three ECM components we have studied are distributed in distinct temporal and spatial patterns. Prior to preplate formation, immunolabeling for FN and a CSPG is distributed throughout the ventricular zone, with some predominance near the ventricular surface. As newly generated cells leave the ventricular zone to form the preplate, punctate aggregates of FN associated with radial glia, and a prominent, diffuse accumulation of CSPG Figure 5 . Cortical plate formation divides distribution of FN: tracing of three overlapping photographic double exposures (similar to those shown in Fig. 4 ) labeled with abFN (black dots) and RC2 (thin lines). Section is from the ventrolateral cortex early on E 13 in an area where the cortical plate (CP) is forming in the more mature cortex on the right (between broken lines) and the preplate (PPZ) is undivided in the less mature cortex on the left. FN is present along radial glia in a continuous band in the preplate; after cortical plate formation it is present along radial glia in the subplate (SP) and marginal zone (MZ) but very sparse in the cortical plate. Labeling of the blood vessels by abFN is shown as light shading, labeling associated with the pia-arachnoid has been omitted. Scale bar, 50 pm.
appear in the preplate. Cortical plate formation within the preplate divides the latter into the marginal zone and subplate, and the distribution of FN and CSPG is similarly divided. Slightly later, as the accumulation of the cortical plate advances, the distribution of FN in the subplate becomes diffuse rather than punctate (Stewart and Pearlman, 1987) . Immunolabeling for tenascin appears late in the CP stage, at a time when labeling for FN has all but disappeared and labeling of CSPG is declining rapidly. It is detectable first in the subplate and marginal zone, then gradually appears in all cortical layers as they differentiate, and in the subcortical white matter. As the barrel field forms in the somatosensory cortex, tenascin immunolabeling is excluded from the relatively cell-free hollows of the barrels. Immunolabeling for tenascin declines rapidly during the second postnatal week.
The redistribution of FN and CSPG during early cortical development: association with preplate cells and radial glia Our observations indicate that the laminar distribution of FNand CSPG-like immunoreactivity in early cortical development is related to the distribution of preplate cells and that punctate abFN labeling is also closely associated with radial glia.
Both preplate cells and radial glia are only transiently present during cortical formation. Radial glia appear to guide migrating neurons from the ventricular zone to the cortical plate (Ramon y Cajal, 1891; Rakic, 1972) and are then transformed into astrocytes (Ramon y Cajal, 1911; Schmechel and Rakic, 1979; Levitt et al., 198 1; Pixley and de Vellis, 1984; Voigt, 1989; Culican et al., 1990) . Preplate cells are the first postmitotic cells to leave the proliferative zone. Many are clearly neurons since they form synapses, contain neuropeptides, are labeled by antibodies to a neuronal microtubule-associated protein (MAP2; Chun and Shatz, 1989) , and extend the first axons to leave the cortex (McConnell et al., 1989; De Carlos and O'Leary, 1990; Bicknese et al., 1991) . Some preplate cells may be glia, since they have distinct glia-like end feet in contact with the pial basement membrane; cells with this characteristic are later positive for glial fibrillary acidic protein (Rickmann and Wolff, 1985; Choi, 1988) . The cortical plate, which will form definitive cortex, is assembled within the layer of preplate cells and the early axons that course among them (Marin-Padilla, 1978) . Some preplate neurons will survive as the Cajal-Retzius cells of the molecular layer and as interstitial neurons in the subcortical white matter (Kostovic and Rakic, 1980; Luskin and Shatz, 1985; Valverde and Fatal-Valverde, 1987; Al-Ghoul and Miller, 1989; Valverde et al., 1989) ; a large proportion are lost in both the cat and the rodent (Luskin and Shatz, 1985; Woo et al., 1990) . The presumptive preplate glia appear to proliferate to produce astrocytes and perhaps other glial types as well (Rickmann and Wolff, 1985) .
The close association of immunolabeling for both FN and CSPG with preplate cells and for FN with radial glia suggests that one or both of these cell types are producing F'N and CSPG, or are responsible for their local accumulation. Destruction of subplate neurons with excitotoxins results in marked local diminution of FN, supporting the concept that FN and subplate cells are closely associated (Chun and Shatz, 1988) . However, the transient nature of both radial glia and preplate cells does not directly account for the transient presence of FN and CSPG. Immunoreactivity for FN becomes virtually undetectable in the mouse by El 6-l 8 and for CSPG by E 18, whereas the transformation of radial glia to astrocytes takes place largely between E 17 and P2 (Takahashi et al., 1990 ) and preplate cells are lost even later (Luskin and Shatz, 1985; Woo et al., 1990) . Whether the decline in immunolabeling for FN and CSPG is caused by reduced synthesis and deposition or by enhanced degradation (Emonard and Grimaud, 1990) remains to be determined.
Hypotheses for the roles of ECM in early cortical development As discussed previously (Stewart and Pearlman, 1987) no matter what roles FN and CSPG play in early cortical development, they are probably doing so in conjunction with other ECM components, since several have been described with a similar distribution. These include undefined glycosaminoglycans la- (Derer and Nakanishi, 1983; Nakanishi, 1983) , and in the subplate and marginal zones with lectins (Bruckner et al., 1985) . Hyaluronectin is demonstrable with antibodies in a similar distribution in the rat (Delpech and Delpech, 1984; Bignami and Delpech, 1985) . ECM is evident by electron microscopy in the subplate and marginal zones (Derer and Nakanishi, 1983; Hankin and Silver, 1988) . These studies have emphasized the association of ECM with either neurons (Derer and Nakanishi, 1983; Nakanishi, 1983) or astrocytes and microglia (Bruckner et al., 1985) . An association of ECM with radial glia was suggested by the observation of punctate immunoreactivity for laminin, but not FN, in linear arrays in cerebral hemispheres, diencephalon, and mesencephalon, and along Bergmann glia in the cerebellum (Liesi, 1985) . It remains to be determined whether laminin undergoes a redistribution in cortex similar to that which we found for FN; although we have used several monoclonal and polyclonal antibodies to laminin, we have found only faint punctate accumulations of immunoreactivity with a distribution that is approximately similar to that of FN (data not shown). In other sites where punctate aggregates of FN immunoreactivity are present, such as the migratory pathway of neural crest cells (Brauer and Markwald, 1988) and the developing heart (Mjaatvedt et al., 1987) , FN is thought to be a central constituent of complexes that contain other ECM components.
ECA4 in neurite outgrowth. The suggestion that ECM serves as a guide for axonal extension (Stewart and Pearlman, 1987; Chun and Shatz, 1988; Letourneau et al., 1988) has been prominent in most of the reports on ECM distribution in developing cortex, primarily because early neuronal processes occupy the preplate, marginal zones, and subplate (Marin-Padilla, 1978; Schlumpf et al., 1980; Caviness and Korde, 198 1; Lidov and Molliver, 1982; Vemey et al., 1982; Crandall and Caviness, 1984; McConnell et al., 1989) where ECM is prominent. The importance of ECM components in neurite outgrowth has been underlined by numerous studies of central and peripheral neurons in tissue culture (Hauschka and Ose, 1979; Akers et al., 1981; Manthorpe et al., 1983; Rogers et al., 1983 Rogers et al., , 1987 Liesi et al., 1984; Smallheiser et al., 1984; Adler et al., 1985; Hammarback et al., 1985; Neugebauer et al., 1988; Tomaselli and Reichardt, 1988; Tomaselli et al., 1988; Humphries et al., 1989; Reichardt and Tomaselli, 199 1) .
Our observation that the shift of FN to the preplate takes place just before the first neuronal processes are demonstrable in that layer with neurofilament antibodies lends support to the idea that ECM is involved in defining a terrain for process extension. Whether the neuronal processes in the preplate are afferent axons, as suggested by Golgi studies (Marin-Padilla, 1978) , or local and efferent processes of preplate-subplate cells, as indicated by fluorescent tracers at slightly later stages (McConnell et al., 1989; De Carlos and O'Leary, 1990) , remains to be determined. In two other axon tracts of the CNS, laminin, but not FN, is present in punctate arrays during early axonal elongation (Letoumeau et al., 1988; Liesi and Silver, 1988) . In these studies and in ours, antibodies to neurofilaments were used to identify axons. Since the expression of the neurofilament proteins recognized by these antibodies may not be completely synchronous with axonal elongation in very immature axons, these studies provide only a close approximation of the time of axonal extension. In contrast to our finding that a CSPG is prominent in preplate-derived layers that contain numerous extending axons (Crandall and Caviness, 1984) sulfated glycosaminoglycans have been implicated in establishing barriers to axon outgrowth in other sites. Keratin sulfate is present in association with the glial cells of the roof plate in the spinal cord of the chick and in the midline of the optic tectum of the hamster (Snow et al., 1990b) . Axons growing near these areas do not invade them even though they contain ample extracellular space, suggesting that keratin sulfate, and perhaps other glycosaminoglycans, may inhibit axonal extension (Snow et al., 1990b) . Similarly, the posterior sclerotome, which is avoided by the growing axons of spinal motor neurons, contains high levels ofglycosaminoglycans (Tosney and Landmesser, 1985) . In tissue culture, processes of chick dorsal root ganglia grow extensively on stripes of laminin, but avoid adjacent stripes coated with keratin sulfate/CSPG (Snow et al., 1990a) . Heparin and hyaluronic acid are also inhibitory to neurite outgrowth from these cells (Carbonetto et al., 1983) , and chondroitin sulfates inhibit neurite outgrowth from PC12 cells (Oohira et al., 199 1) .
The apparent conflict between our observations and those that suggest that proteoglycans serve as barriers to axonal outgrowth (Snow et al., 1990a,b) may be a manifestation of the diversity of proteoglycans. There is a wide variety of proteoglycan core proteins with varying amounts of one or more types of glycosaminoglycan attached (Gallagher, 1989) . Furthermore, a single class of glycosaminoglycan is not homogeneous; chondroitin sulfates, for example, may vary in molecular mass from 5 to 50 kDa depending on the number of disaccharides in the polymer chain, and the number of sulfates per disaccharide unit is also variable. Proteoglycans also vary considerably in function. Various ECM proteoglycans have been shown to either support, hinder, or block completely the binding of cell surface integrins to other ECM components, and to bind directly to nonintegrin cell surface ligands (Gallagher, 1989) . Cell surface proteoglycans may also mediate interactions with ligands on other cells, as in the binding of the cytotactin-binding proteoglycan of neurons with cytotactin ofglia (Hoffman and Edelman, 1987) . Thus, differences in proteoglycan structure may make them intrinsically more or less attractive to growing axons (Oohira et al., 199 1) . Alternatively, it has been suggested that proteoglycans may bind varying amounts of other matrix components such as FN laminin, which would produce differences in their ability to support neurite outgrowth (Snow et al., 1990a) . Our findings suggest that the CSPG demonstrable with the an- (Avnur and Geiger, 1984) does not have an inhibitory or barrier role; additional analysis will be required to determine which of the many proteoglycans present in developing brain (Oohira et al., 1988; Margolis and Margolis, 1989; Herndon and Lander. 1990 ) this antibody labels.
ECM in neuronal migration. The second major set of hypotheses regarding the role of ECM implicates matrices in the migration of neurons from the ventricular zone to the cortical plate along radial glia (Liesi, 1985) or in the formation of the cortical plate at the end of that migration (Stewart and Pearlman, 1987; Chun and Shatz, 1988) . The shift in distribution of FN and CSPG takes place in conjunction with the migration of preplate cells. It has been suggested that FN may be responsible for holding preplate cells in the ventricular zone (Stallcup et al., 1989) ; its loss there may allow them to move into the preplate zone either by nuclear translocation and process retraction (Morest, 1970) or by migration along radial glia (Rakic, 1972) . Since the shift in distribution of FN and CSPG takes place before the migration of the first cortical plate neurons, it is not likely that they serve as a substrate for this migration. As we suggested earlier (Stewart and Pearlman, 1987) , ECM is appropriately located to offer a signal to arriving neurons that they are approaching the end of their journey. To extend this hypothesis, we suggest that radial glia, preplate cells, and the ECM might constitute a framework for subsequent cortical plate formation. Cortical plate neurons would invade that framework and establish residence within it; radial glia would continue to elongate as the cortical plate expands, but the former preplate cells, now located above and below the cortical plate, would maintain their relative positions, held in place by FN, CSPG, and other ECM components, and perhaps by ECM-mediated connections to the radial glia.
Role of tenascin in late cortical development A role in neuronal migration has been suggested for tenascin (cytotactin) because of its distribution in the developing cerebellum and the ability of anti-cytotactin antibodies to block granule cell migration partially in cerebellar slices (Crossin et al., 1989) . However, tenascin immunolabeling appears late in development relative to the migration of most cortical neurons (Godfraind et al., 1988; Crossin et al., 1989; present study) . At El6 in the mouse, when we first detect immunolabeling in the subplate and marginal zone, the cortical plate has already reached maximal thickness. Even though more neurons will be added to the top of the cortical plate as those at the base mature, the neurons that comprise the cortical plate at this stage have already completed their migration, suggesting that tenascin does not have a role in the migration of a large proportion of cortical neurons, nor does the distribution of immunolabeling for tenastin correlate either spatially or temporally with the establishment of the major efferent or afferent cortical pathways. Efferents from preplate neurons are evident in the intermediate zone of both rat and mouse in the preplate stage (De Carlos and O'Leary, 1990; Bicknese et al., 1991) . Efferents from cortical neurons are demonstrable very soon after the cortical plate is formed; afferents from the thalamus are demonstrable 12-24 hr later (De Carlos and O'Leary, 1990; Reinoso and O'Leary, 1990; Bicknese et al., 199 1) . In contrast, immunolabeling for tenascin is not evident in the subplate until approximately 72 hr after cortical plate formation (present study). Immunolabeling for tenascin subsequently appears in both the differentiating cortex and the subcortical white matter; the latter contains numerous axonal processes that are already well established. The suggestion that tenascin (J 1) is providing a barrier to neurite outgrowth (Steindler et al., 1989 (Steindler et al., , 1990 Faissner and Kruse, 1990 ) may hold for the processes growing within the hollows of cortical vibrissal barriers, but appears not to be the case for the remainder of differentiating cortex where tenascin expression is diffuse in locations where growth of axons and dendrites is extensive. Most recent evidence indicates that the restriction of labeling for tenascin and other glycoconjugates to the barrel walls is actually dependent on the prior formation of a barrel pattern by thalamic afferents (Christensen et al., 1990; Schlagger and O'Leary, 1990, 199 1; Jhaveri et al., 1991) .
Several lines of evidence suggest that tenascin is closely associated with glia. It is synthesized by glia in culture (Grumet et al., 1985; Hoffman et al., 1988; Crossin et al., 1989) , associated predominantly with glial membranes by electron microscopy (Steindler et al., 1989) and prominent in the walls of cortical barrels that contain astrocytes demonstrable with antibodies to glial fibrillary acidic protein (Steindler et al., 1989) . From this evidence, we suggest that immunolabeling for tenastin in cortex represents the expression of the molecule on the surface of developing glial cells or in their pericellular environment. The expression occurs first in marginal zone and subplate, the most mature of the layers, at the time when definitive astrocytes are evident in these layers (E16-17; Rickmann and Wolff, 1985) . Extension of tenascin expression into the cortical plate as it matures from deep layers to superficial, and in the subcortical white matter, corresponds exactly to the time (E 17 to P2) when extensively branched astrocytes become apparent in these layers, many as the result of transformation of radial glia to astrocytes (Rickman and Wolff, 1985; Takahashi et al., 1990) . Thus, the developmental event that correlates best with the expression of tenascin is the extensive outgrowth of glial processes that occurs with early cortical maturation. Its expression does not appear to be related to either the neuronal migration that establishes the preplate and cortical plate or the axonal extensions that establish major axonal pathways. Immunolabeling is present throughout the cortex but is sparse in the small, densely packed residual cortical plate (0). P4, Cortical plate is no longer evident; immunolabeling is present throughout cortex. P7, Parietal cortex, barrel field. Immunolabeling is absent from the barrel hollows (*), present in the barrel wall and in the remainder of cortex, but declining in lower layers. PIO, Immunolabeling is nearly undetectable except in association with blood vessels. I-VZ, layers I-VI; SP, subplate; WM. white matter. Scale bar, 20 pm.
